515 related articles for article (PubMed ID: 36532043)
1. Risk of psoriasis in people with hidradenitis suppurativa: A systematic review and meta-analysis.
Gau SY; Preclaro IAC; Wei JC; Lee CY; Kuan YH; Hsiao YP; Juang SE; Ma KS
Front Immunol; 2022; 13():1033844. PubMed ID: 36532043
[TBL] [Abstract][Full Text] [Related]
2. Risk of liver dysfunction and non-alcoholic fatty liver diseases in people with hidradenitis suppurativa: A systematic review and meta-analysis of real-world evidences.
Gau SY; Hsiao YP; Liao WC; Ma KS; Wu MC
Front Immunol; 2022; 13():959691. PubMed ID: 36591267
[TBL] [Abstract][Full Text] [Related]
3. Risk of Atopic Diseases in Patients with Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis of Observational Studies.
Gau SY; Chan WL; Tsai JD
Dermatology; 2023; 239(2):314-322. PubMed ID: 36623494
[TBL] [Abstract][Full Text] [Related]
4. Psoriasis and hidradenitis suppurativa: A large-scale population-based study.
Kridin K; Shani M; Schonmann Y; Fisher S; Shalom G; Comaneshter D; Batat E; Cohen AD
J Am Acad Dermatol; 2023 May; 88(5):e231-e236. PubMed ID: 30502412
[TBL] [Abstract][Full Text] [Related]
5. Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.
Pinter A; Sarlak M; Zeiner KN; Malisiewicz B; Kaufmann R; Romanelli M; Koenig A; Chiricozzi A
Dermatology; 2021; 237(5):759-768. PubMed ID: 33326954
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population.
Kirsten N; Zander N; Augustin M
Arch Dermatol Res; 2021 Mar; 313(2):95-99. PubMed ID: 32322958
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis.
Jfri A; Nassim D; O'Brien E; Gulliver W; Nikolakis G; Zouboulis CC
JAMA Dermatol; 2021 Aug; 157(8):924-931. PubMed ID: 34037678
[TBL] [Abstract][Full Text] [Related]
8. Anemia in patients with hidradenitis suppurativa : A systematic review with meta-analysis.
Revankar R; Rojas M; Walsh S; Patel H; Revankar N; Han J; Parameswaran A
Arch Dermatol Res; 2023 Aug; 315(6):1639-1648. PubMed ID: 36781458
[TBL] [Abstract][Full Text] [Related]
9. Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa.
Reddy S; Strunk A; Garg A
JAMA Dermatol; 2019 Jul; 155(7):797-802. PubMed ID: 30994865
[TBL] [Abstract][Full Text] [Related]
10. Co-morbidities in inflammatory dermatological diseases. Psoriasis, hidradenitis suppurativa, and cardiovascular risk factors.
Miller IM
Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324088
[TBL] [Abstract][Full Text] [Related]
11. Association Between Hidradenitis Suppurativa and Metabolic Syndrome: A Systematic Review and Meta-analysis.
Rodríguez-Zuñiga MJM; García-Perdomo HA; Ortega-Loayza AG
Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):279-288. PubMed ID: 30846164
[TBL] [Abstract][Full Text] [Related]
12. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
Garg A; Malviya N; Strunk A; Wright S; Alavi A; Alhusayen R; Alikhan A; Daveluy SD; Delorme I; Goldfarb N; Gulliver W; Hamzavi I; Jaleel T; Kimball AB; Kirby JS; Kirchhof MG; Lester J; Lev-Tov H; Lowes MA; Micheletti R; Orenstein LA; Piguet V; Sayed C; Tan J; Naik HB
J Am Acad Dermatol; 2022 May; 86(5):1092-1101. PubMed ID: 33493574
[TBL] [Abstract][Full Text] [Related]
13. Association between Hidradenitis Suppurativa and Inflammatory Arthritis: A Systematic Review and Meta-Analysis.
Almuhanna N; Finstad A; Alhusayen R
Dermatology; 2021; 237(5):740-747. PubMed ID: 33774640
[TBL] [Abstract][Full Text] [Related]
14. The differentiating effect of COVID-19-associated stress on the morbidity of blood donors with symptoms of hidradenitis suppurativa, hyperhidrosis, or psoriasis.
Henning MAS; Didriksen M; Ibler KS; Ostrowski SR; Erikstrup C; Nielsen K; Sækmose SG; Hansen TF; Ullum H; Thørner LW; Kaspersen KA; Mikkelsen S; Jemec GBE; Pedersen OB
Qual Life Res; 2023 Oct; 32(10):2925-2937. PubMed ID: 37270451
[TBL] [Abstract][Full Text] [Related]
15. Psoriasis as a comorbidity of hidradenitis suppurativa.
Kjaersgaard Andersen R; Saunte SK; Jemec GBE; Saunte DM
Int J Dermatol; 2020 Feb; 59(2):216-220. PubMed ID: 31591714
[TBL] [Abstract][Full Text] [Related]
16. Phenotypes and Pathophysiology of Syndromic Hidradenitis Suppurativa: Different Faces of the Same Disease? A Systematic Review.
Nikolakis G; Kaleta KP; Vaiopoulos AG; Wolter K; Baroud S; Wojas-Pelc A; Zouboulis CC
Dermatology; 2021; 237(5):673-697. PubMed ID: 32942279
[TBL] [Abstract][Full Text] [Related]
17. Risk of Chronic Kidney Disease in Hospitalized Patients with Hidradenitis Suppurativa.
Almuhanna N; Tobe SW; Alhusayen R
Dermatology; 2023; 239(6):912-918. PubMed ID: 37487485
[TBL] [Abstract][Full Text] [Related]
18. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
[TBL] [Abstract][Full Text] [Related]
19. Association of metabolic syndrome and hidradenitis suppurativa.
Miller IM; Ellervik C; Vinding GR; Zarchi K; Ibler KS; Knudsen KM; Jemec GB
JAMA Dermatol; 2014 Dec; 150(12):1273-80. PubMed ID: 25229996
[TBL] [Abstract][Full Text] [Related]
20. Screening for Diabetes Mellitus in Patients with Hidradenitis Suppurativa-A Monocentric Study in Germany.
Abu Rached N; Gambichler T; Ocker L; Dietrich JW; Quast DR; Sieger C; Seifert C; Scheel C; Bechara FG
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
